Sigrid Carlsson

Summary

Affiliation: Lund University
Country: Sweden

Publications

  1. ncbi request reprint Anxiety associated with prostate cancer screening with special reference to men with a positive screening test (elevated PSA) - Results from a prospective, population-based, randomised study
    Sigrid Carlsson
    Department of Urology, Sahlgrenska University Hospital, Bruna stråket 11 B, SE 413 45 Goteborg, Sweden
    Eur J Cancer 43:2109-16. 2007
  2. doi request reprint The excess burden of side-effects from treatment in men allocated to screening for prostate cancer. The Göteborg randomised population-based prostate cancer screening trial
    Sigrid Carlsson
    Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Göteborg, Bruna Straåket 11B, Goteborg, Sweden
    Eur J Cancer 47:545-53. 2011
  3. pmc Mortality results from the Göteborg randomised population-based prostate-cancer screening trial
    Jonas Hugosson
    Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Göteborg, Sweden
    Lancet Oncol 11:725-32. 2010
  4. doi request reprint The absence of voiding symptoms in men with a prostate-specific antigen (PSA) concentration of ≥3.0 ng/mL is an independent risk factor for prostate cancer: results from the Gothenburg Randomized Screening Trial
    Maria Frånlund
    Department of Urology, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
    BJU Int 110:638-43. 2012
  5. pmc Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study
    Sigrid Carlsson
    Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sweden
    BMJ 348:g2296. 2014
  6. doi request reprint Nationwide population-based study on 30-day mortality after radical prostatectomy in Sweden
    Sigrid Carlsson
    Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Scand J Urol Nephrol 43:350-6. 2009

Detail Information

Publications6

  1. ncbi request reprint Anxiety associated with prostate cancer screening with special reference to men with a positive screening test (elevated PSA) - Results from a prospective, population-based, randomised study
    Sigrid Carlsson
    Department of Urology, Sahlgrenska University Hospital, Bruna stråket 11 B, SE 413 45 Goteborg, Sweden
    Eur J Cancer 43:2109-16. 2007
    ..0001) and with increasing age (p=0.0016). Anxiety associated with prostate cancer screening in general is low to moderate, even in men with elevated PSA, and severe anxiety affects a smaller group of susceptible men...
  2. doi request reprint The excess burden of side-effects from treatment in men allocated to screening for prostate cancer. The Göteborg randomised population-based prostate cancer screening trial
    Sigrid Carlsson
    Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Göteborg, Bruna Straåket 11B, Goteborg, Sweden
    Eur J Cancer 47:545-53. 2011
    ..The aim of this study was to evaluate the treatment related morbidity following radical prostatectomy in men participating in the Göteborg randomised population-based prostate cancer screening trial...
  3. pmc Mortality results from the Göteborg randomised population-based prostate-cancer screening trial
    Jonas Hugosson
    Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Göteborg, Sweden
    Lancet Oncol 11:725-32. 2010
    ..One strategy to decrease the risk of death from this disease is screening with prostate-specific antigen (PSA); however, the extent of benefit and harm with such screening is under continuous debate...
  4. doi request reprint The absence of voiding symptoms in men with a prostate-specific antigen (PSA) concentration of ≥3.0 ng/mL is an independent risk factor for prostate cancer: results from the Gothenburg Randomized Screening Trial
    Maria Frånlund
    Department of Urology, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
    BJU Int 110:638-43. 2012
    ..The main conclusion was that the absence of voiding symptoms is an independent risk factor for prostate cancer detection...
  5. pmc Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study
    Sigrid Carlsson
    Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sweden
    BMJ 348:g2296. 2014
    ..To determine the relative risks of prostate cancer incidence, metastasis, and mortality associated with screening by serum prostate specific antigen (PSA) levels at age 60...
  6. doi request reprint Nationwide population-based study on 30-day mortality after radical prostatectomy in Sweden
    Sigrid Carlsson
    Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Scand J Urol Nephrol 43:350-6. 2009
    ..Radical prostatectomy (RP) is currently commonly performed, either within or outside large high-volume centres. The aim of this study was to assess the 30-day mortality rate after RP in Sweden...